Pharmafile Logo
Pharmafocus logo
Advanced Search
covid_cell

COVID-19 vaccine eligibility creates challenges for UK pharmacies

October 8, 2025
Medical Communications COVID-19, NHS, pharmacies, vaccinations

Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments despite no longer meeting the …

News

Celtic Renewables pushes for use of bio-based materials in pharma industry

October 8, 2025
Manufacturing and Production Celtic Renewables, Green Chemicals, sustainability

The company produces low-carbon, sustainable bio-based chemicals

News

Esaote presents new MRI system to support brain glioma surgeries

October 7, 2025
Research and Development Esaote, MRI, medical imaging, neurology

Gliomas are among the most common primary malignant brain tumours

News
drug-trials

Bio-Rad signs exclusive European distribution deal with Gencurix for oncology testing kits

October 6, 2025
Research and Development Bio-Rad, Diagnostics and Testing, Gencurix, oncology

The agreement expands access to oncology testing kits across Europe

News

Novel excipients: the key to unlocking drug innovation

October 6, 2025
Business Services Lubrizol, Pharmacy

ADVERTORIAL, IN ASSOCIATION WITH LUBRIZOL Meera Raghuram, Director of Regulatory and Sustainability Strategy at Lubrizol, explores how formulators can overcome …

Feature
Thought Leadership

The Pharma Files: With Colin Williams from Astellas Pharma

October 5, 2025
Medical Communications, Research and Development Astellas Pharma, Corporate, The Pharma Files, pm society

Pharmafile chats with Colin Williams, Head of Marketing Excellence, Global Capabilities, Learning & Development at Astellas Pharma about the best …

Feature

How can optichannel engagement drive return on investment across the product life cycle?

October 3, 2025
Business Services, Consultancy Corporate, PharmaForceIQ, Pharmacy, chief strategy officer, optichannel engagement

HCPs and patients are demanding personalised, streamlined experiences. Hemal Somaiya, Chief Strategy Officer, PharmaForceIQ, discusses how optichannel engagement offers a …

Feature

Chronic spontaneous urticaria – the impact on patient quality of life, ongoing developments in treatments and the importance of greater awareness

October 3, 2025
Medical Communications, Research and Development Dermatology, Immunology, acute urticaria, chronic spontaneous urticaria, dermatology, immunology

The current forms of immunotherapy, how T cell therapy works and what the future holds

Feature

From sickness to prevention: the case for population health management

October 3, 2025
Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy

In the third of the Gateway to Local Adoption series, Visions4Health caught up with James Scott, Digital and Informatics Specialist …

Feature

Micrima announces upcoming launch of new UK breast cancer assessment

October 3, 2025
Research and Development Micrima, breast cancer, oncology

Breast cancer remains one of the leading health threats to women over 35 in the UK Micrima, a healthcare technology …

News

Latham & Watkins appoints Lydia Torne as life sciences and IP partner

October 3, 2025
Latham & Watkins, intellectual property

Appointment brings specialist healthcare IP commercialisation expertise to the firm Latham & Watkins has appointed Lydia Torne as a partner …

Appointment

Veranova appoints Joe Torres-Ocasio as senior vice president and chief operating officer

October 2, 2025
Veranova, antibody-drug conjugates, appointment

Appointment follows significant investment into US manufacturing footprint Active pharmaceutical ingredient (API) manufacturer Veranova has appointed Joe Torres-Ocasio as senior …

Appointment

Pierre Fabre partners with Know Your Lemons Foundation for breast cancer awareness

October 2, 2025
Medical Communications Education, Pierre Fabre, breast cancer

The campaign focuses on early detection and education Pierre Fabre Laboratories has announced a partnership with the Know Your Lemons …

News
partnership

Nanoform partners with A&LS Pharma

October 2, 2025
Research and Development A&LS Pharma, Nanoform

Distribution agreement will make Nanoform’s products available in South Korea Nanoform Finland has entered into a distribution agreement with Ageing …

News

From Vaccine Innovation Pathway to growth powerhouse: how the UK is transforming clinical trials

October 2, 2025
Business Services, Market Access, Market Access Consultancy, Sales and Marketing 10 Year Health Plan, Life Sciences Sector Plan, NHS, National Institute for Health and Care Research, Pharmacy, UK Vaccine Innovation Pathway

Commercial clinical trials are a high-value growth driver for a country’s health and the economy and a key component of …

Feature
Thought Leadership

Five Facts about Breast Cancer

October 2, 2025
Medical Communications Breast Cancer Awareness Month, Five Facts, Oncology, breast cancer

1 There are striking inequities in breast cancer burden regarding the Human Development Index (HDI), the United Nation’s measure of …

Feature

Unlocking nature’s pharmacy: how tea leaves and marine organisms could help transform breast cancer treatment

October 2, 2025
Research and Development King Abdullah University of Science and Technology, Oncology, natural products chemistry, triple-negative breast cancer

Looking beyond synthetic chemistry to unlock powerful, naturally derived medicines Each year, World Breast Cancer Awareness Month serves as a …

Feature

Sanofi and Regeneron’s Dupixent receives CHMP recommendation for chronic spontaneous urticaria

September 26, 2025
Research and Development Dupixent, Regeneron, Sanofi, urticaria

Sanofi and Regeneron have received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …

News
hsm_mobile_clinical_trial_istock-872676342

CSL Behring’s angioedema treatments receives NICE recommendation

September 26, 2025
Regulatory Affairs, Research and Development Andembry, CSL Behring, hereditary angioedema

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending CSL Behring’s ANDEMBRY (garadacimab) for …

News
drug-trials

Gilead Foundation awards $6.5m in grants to support STEM education

September 26, 2025
Research and Development Funding and Investment, Gilead Sciences, stem

Gilead Sciences has committed over $6.5m in grant funding towards improving science, technology, engineering and maths (STEM) education, the company …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026